Cost-effectiveness of cell salvage and alternative methods of minimising perioperative allogeneic blood transfusion: a systematic review and economic model. （開啟新視窗）

Davies L, Brown TJ, Haynes S, Payne K, Elliott RA, McCollum C.

出處‎: Health Technol Assess 2006;10(44):1-228.

檢索‎: PubMed 17049141

https://www.ncbi.nlm.nih.gov/pubmed/17049141 （開啟新視窗）

Estimating the epidemiological and economic impact of implementing preoperative anaemia measures in the German healthcare system: the health economic footprint of patient blood management. （開啟新視窗）

Drabinski T, Zacharowski K, Meybohm P, Rüger AM, Ramirez de Arellano A

出處‎: Adv Ther 2020;37(8):3515-36.

檢索‎: PubMed 32562124

DOI碼‎: 10.1007/s12325-020-01372-4

https://www.ncbi.nlm.nih.gov/pubmed/32562124 （開啟新視窗）

Greater than sevenfold return on investment for a comprehensive patient blood management program with equivalent or improved outcomes. （開啟新視窗）

Frank SM, Hensley NB, Thomas AJ, Dawson CG, Resar LMS, Ulatowski JA, Crowe EP

出處‎: Anesth Analg 2024;138(6):1345-48.

檢索‎: PubMed 38530909

DOI碼‎: 10.1213/ANE.0000000000006862

https://pubmed.ncbi.nlm.nih.gov/38530909/ （開啟新視窗）

Risk-adjusted clinical outcomes in patients enrolled in a bloodless program. （開啟新視窗）

Frank SM, Wick EC, Dezern AE, Ness PM, Wasey JO, Pippa AC, Dackiw E, Resar LM.

出處‎: Transfusion 2014;54(10 Pt 2):2668-77.

檢索‎: PubMed 24942198

DOI碼‎: 10.1111/trf.12752

https://www.ncbi.nlm.nih.gov/pubmed/24942198 （開啟新視窗）

Economic considerations on transfusion medicine and patient blood management. （開啟新視窗）

Hofmann A, Ozawa S, Farrugia A, Farmer SL, Shander A.

出處‎: Best Pract Res Clin Anaesthesiol 2013;27(1):59-68.

檢索‎: PubMed 23590916

DOI碼‎: 10.1016/j.bpa.2013.02.001

https://www.ncbi.nlm.nih.gov/pubmed/23590916 （開啟新視窗）

Tranexamic acid reduces blood loss and financial cost in primary total hip and knee replacement surgery. （開啟新視窗）

Irisson E, Hémon Y, Pauly V, Parratte S, Argenson JN, Kerbaul F.

出處‎: Orthop Traumatol Surg Res 2012;98(5):477-83.

檢索‎: PubMed 22854336

DOI碼‎: 10.1016/j.otsr.2012.05.002

https://www.ncbi.nlm.nih.gov/pubmed/22854336 （開啟新視窗）

Blood product conservation is associated with improved outcomes and reduced costs after cardiac surgery. （開啟新視窗）

LaPar DJ, Crosby IK, Ailawadi G, Ad N, Choi E, Spiess BD, Rich JB, Kasirajan V, Fonner E Jr, Kron IL, Speir AM; Investigators for the Virginia Cardiac Surgery Quality Initiative.

出處‎: J Thorac Cardiovasc Surg 2013;145(3):796-804.

檢索‎: PubMed 23414992

DOI碼‎: 10.1016/j.jtcvs.2012.12.041

https://www.ncbi.nlm.nih.gov/pubmed/23414992 （開啟新視窗）

From blood transfusion to patient blood management: a new paradigm for patient care and cost assessment of blood transfusion practice. （開啟新視窗）

Leahy MF, Mukhtar SA.

出處‎: Intern Med J 2012;42(3):332-8.

檢索‎: PubMed 22432987

DOI碼‎: 10.1111/j.1445-5994.2012.02717.x

https://www.ncbi.nlm.nih.gov/pubmed/22432987 （開啟新視窗）

Safety, cost savings, simplicity back broader use of bloodless surgery. （開啟新視窗）

Mathias JM.

出處‎: OR Manager 2013;29(5):1, 6, 8-9.

檢索‎: PubMed 23755462

https://www.ncbi.nlm.nih.gov/pubmed/23755462 （開啟新視窗）

Associations between preoperative anaemia and hospital costs following major abdominal surgery: cohort study. （開啟新視窗）

Meyerov J, Louis M, Lee DK, Fletcher L, Banyasz D, Miles LF, Ma R, Tosif S, Koshy AN, Story DA, Bellomo R, Weinberg L

出處‎: BJS Open 2021;5(2):zraa070.

檢索‎: PubMed 33834189

DOI碼‎: 10.1093/bjsopen/zraa070

https://pubmed.ncbi.nlm.nih.gov/33834189/ （開啟新視窗）

Effects of intravenous iron combined with low-dose recombinant human erythropoietin on transfusion requirements in iron-deficient patients undergoing bilateral total knee replacement arthroplasty. （開啟新視窗）

Na HS, Shin SY, Hwang JY, Jeon YT, Kim CS, Do SH.

出處‎: Transfusion 2011;51(1):118-24.

檢索‎: PubMed 20624257

DOI碼‎: 10.1111/j.1537-2995.2010.02783.x

https://www.ncbi.nlm.nih.gov/pubmed/20624257 （開啟新視窗）

ONTraC: a 20-year history of a successfully coordinated provincewide patient blood management program: Lessons learned and goals achieved. （開啟新視窗）

Pavenski K, Howell A, Mazer CD, Hare GMT, Freedman J

出處‎: Anesth Analg. 2022;135(3):448-58.

檢索‎: PubMed 35977355

DOI碼‎: 10.1213/ANE.0000000000006065

https://pubmed.ncbi.nlm.nih.gov/35977355/ （開啟新視窗）

A prospective study investigating the cost effectiveness of intraoperative blood salvage during liver transplantation. （開啟新視窗）

Phillips SD, Maguire D, Deshpande R, Muiesan P, Bowles MJ, Rela M, Heaton ND.

出處‎: Transplantation 2006;81(4):536-40.

檢索‎: PubMed 16495800

DOI碼‎: 10.1097/01.tp.0000199318.17013.c5

https://www.ncbi.nlm.nih.gov/pubmed/16495800 （開啟新視窗）

Effective reduction of blood product use in a community teaching hospital: when less is more. （開啟新視窗）

Politsmakher A, Doddapaneni V, Seeratan R, Dosik H.

出處‎: Am J Med 2013;126(10):894-902.

檢索‎: PubMed 24054957

DOI碼‎: 10.1016/j.amjmed.2013.06.013

https://www.ncbi.nlm.nih.gov/pubmed/24054957 （開啟新視窗）

Prospective monitoring of plasma and platelet transfusions in a large teaching hospital results in significant cost reduction. （開啟新視窗）

Sarode R, Refaai MA, Matevosyan K, Burner JD, Hampton S, Rutherford C.

出處‎: Transfusion 2010;50(2):487-92.

檢索‎: PubMed 19804569

DOI碼‎: 10.1111/j.1537-2995.2009.02413.x

https://www.ncbi.nlm.nih.gov/pubmed/19804569 （開啟新視窗）

Activity-based costs of blood transfusions in surgical patients at four hospitals. （開啟新視窗）

Shander A, Hofmann A, Ozawa S, Theusinger OM, Gombotz H, Spahn DR.

出處‎: Transfusion 2010;50(4):753-65.

檢索‎: PubMed 20003061

DOI碼‎: 10.1111/j.1537-2995.2009.02518.x

https://www.ncbi.nlm.nih.gov/pubmed/20003061 （開啟新視窗）

Intra-operative cell salvage in South Africa: feasible, beneficial and economical. （開啟新視窗）

Solomon L, von Rahden RP, Allorto NL.

出處‎: S Afr Med J 2013;103(10):754-7.

檢索‎: PubMed 24079629

https://www.ncbi.nlm.nih.gov/pubmed/24079629 （開啟新視窗）

Randomized trial comparing packed red cell blood transfusion with and without leukocyte depletion for gastrointestinal surgery. （開啟新視窗）

Tartter PI, Mohandas K, Azar P, Endres J, Kaplan J, Spivack M.

出處‎: Am J Surg 1998;176(5):462-6.

檢索‎: PubMed 9874434

https://www.ncbi.nlm.nih.gov/pubmed/9874434 （開啟新視窗）

Implementation of a comprehensive patient blood management program for hospitalized patients at a large united states medical center. （開啟新視窗）

Warner MA, Schulte PJ, Hanson AC, Madde NR, Burt JM, Higgins AA, Andrijasevic NM, Kreuter JD, Jacob EK, Stubbs JR, Kor DJ

出處‎: Mayo Clin Proc. 2021;96(12):2980-90.

檢索‎: PubMed 34736775

DOI碼‎: 10.1016/j.mayocp.2021.07.017

https://pubmed.ncbi.nlm.nih.gov/34736775/ （開啟新視窗）

The volume of returned red blood cells in a large blood salvage program: where does it all go? （開啟新視窗）

Waters JH, Dyga RM, Waters JF, Yazer MH.

出處‎: Transfusion 2011;51(10):2126-32.

檢索‎: PubMed 21985047

DOI碼‎: 10.1111/j.1537-2995.2011.03111.x

https://www.ncbi.nlm.nih.gov/pubmed/21985047 （開啟新視窗）

An economic analysis of costs associated with development of a cell salvage program. （開啟新視窗）

Waters JR, Meier HH, Waters JH.

出處‎: Anesth Analg 2007;104(4):869-75.

檢索‎: PubMed 17377098

DOI碼‎: 10.1213/01.ane.0000258039.79028.7c

https://www.ncbi.nlm.nih.gov/pubmed/17377098 （開啟新視窗）